Univariately, no differences in 30% and 50% responder-rate were seen between the groups (Supplementary Table 1)
A 2024 Swedish study followed 3,249 MS patients for an average of 10.6 years and found that obesity was associated with: 4 43% higher risk of reaching EDSS 3 (moderate disability) 40% higher risk of reaching EDSS 4 (significant walking impairment) More rapid cognitive decline Higher MRI activity showing new brain lesions A German study of 1,066 MS patients found that obese patients reached disability milestones more quickly than those with normal weight
Frequently Asked Questions (FAQs) Learn more about how Ozempic impacts the eyes with answers to these frequently asked questions
When should I see a doctor about urination changes on tirzepatide
Common GLP-1 drugs you may have heard of include semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza), and dulaglutide (Trulicity)
That quiet mind, the one that could walk past a bakery without a second thought, gets loud again
